A detailed history of Pfs Investments Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Pfs Investments Inc. holds 15,231 shares of HRTX stock, worth $29,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,231
Previous 14,077 8.2%
Holding current value
$29,091
Previous $32,000 43.75%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$1.11 - $2.88 $1,280 - $3,323
1,154 Added 8.2%
15,231 $18,000
Q1 2023

May 15, 2023

BUY
$1.51 - $3.25 $21,256 - $45,750
14,077 New
14,077 $32,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $227M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Pfs Investments Inc. Portfolio

Follow Pfs Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pfs Investments Inc. with notifications on news.